⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for low grade lung neuroendocrine neoplasm

Every month we try and update this database with for low grade lung neuroendocrine neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut OriginNCT02420691
Advanced Digest...
Duodenal Neuroe...
Functional Panc...
Gastric Neuroen...
Intermediate Gr...
Low Grade Lung ...
Nonfunctional P...
Thymus Neoplasm
Laboratory Biom...
Pharmacological...
Ribociclib
18 Years - M.D. Anderson Cancer Center
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsNCT03375320
Carcinoid Tumor
Functioning Pan...
Intermediate Gr...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Low Grade Lung ...
Lung Neuroendoc...
Lung Neuroendoc...
Metastatic Dige...
Metastatic Dige...
Metastatic Lung...
Metastatic Lung...
Metastatic Panc...
Metastatic Panc...
Metastatic Thym...
Neuroendocrine ...
Neuroendocrine ...
Non-Functioning...
Pancreatic Sero...
Thymic Neuroend...
Unresectable Di...
Unresectable Di...
Unresectable Lu...
Unresectable Pa...
Unresectable Th...
Cabozantinib S-...
Computed Tomogr...
Magnetic Resona...
Placebo Adminis...
Quality-of-Life...
X-Ray Imaging
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: